4.7 Article

An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis

期刊

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
卷 139, 期 1, 页码 152-165

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2016.07.019

关键词

Epidermis; ichthyosis; inflammation; autosomal recessive congenital ichthyosis; congenital ichthyosiform erythroderma; lamellar ichthyosis; Netherton syndrome; epidermolytic ichthyosis; skin; IL-17; TNF-alpha

资金

  1. Foglia Family Foundation Endowment
  2. National Psoriasis Foundation
  3. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057216] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Background: The ichthyoses are rare genetic disorders associated with generalized scaling, erythema, and epidermal barrier impairment. Pathogenesis-basedtherapy is largely lacking because the underlying molecular basis is poorly understood. Objective: We sought to characterize molecularly cutaneous inflammation and its correlation with clinical and barrier characteristics. Methods: We analyzed biopsy specimens from 21 genotyped patients with ichthyosis (congenital ichthyosiform erythroderma, n = 6; lamellar ichthyosis, n = 7; epidermolytic ichthyosis, n = 5; and Netherton syndrome, n = 3) using immunohistochemistry and RT-PCR and compared them with specimens from healthy control subjects, patients with atopic dermatitis (AD), and patients with psoriasis. Clinical measures included the Ichthyosis Area Severity Index (IASI), which integrates erythema (IASI-E) and scaling (IASI-S); transepidermal water loss; and pruritus. Results: Ichthyosis samples showed increased epidermal hyperplasia (increased thickness and keratin 16 expression) and Tcell and dendritic cell infiltrates. Increases of general inflammatory (IL-2), innate (IL-1 beta), and some TH1/interferon (IFN-gamma) markers in patients with ichthyosis were comparable with those in patients with psoriasis or AD. TNF-alpha levels in patients with ichthyosis were increased only in those with Netherton syndrome but were much lower than in patientswith psoriasis and those withAD. Expression of TH2 cytokines (IL-13 and IL-31) was similar to that seen in control subjects. The striking induction of IL-17-related genes or markers synergistically induced by IL-17 and TNF-alpha (IL-17A/C, IL-19, CXCL1, PI3, CCL20, and IL36G; P <.05) in patients with ichthyosis was similar to that seen in patients with psoriasis. IASI and IASI-E scores strongly correlated with IL-17A (r = 0.74, P <.001) and IL-17/TNF-synergistic/additive gene expression. These markers also significantly correlated with transepidermal water loss, suggesting a link between the barrier defect and inflammation in patients with ichthyosis. Conclusion: Our data associate a shared TH17/IL-23 immune fingerprint with the major orphan forms of ichthyosis and raise the possibility of IL-17-targeting strategies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Allergy

Ovomucoid epitope-specific repertoire of IgE, IgG4, IgG1, IgA1, and IgD antibodies in egg-allergic children

Maria Suprun, Robert Getts, Galina Grishina, Angela Tsuang, Mayte Suarez-Farinas, Hugh A. Sampson

ALLERGY (2020)

Article Allergy

Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis

Benjamin Ungar, Ana B. Pavel, Randall Li, Grace Kimmel, John Nia, Peter Hashim, Hee Jin Kim, Margot Chima, Anjali S. Vekaria, Yeriel Estrada, Hui Xu, Xiangyu Peng, Giselle K. Singer, Danielle Baum, Yasaman Mansouri, Mark Taliercio, Emma Guttman-Yassky

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Allergy

Vascular inflammation in moderate-to-severe atopic dermatitis is associated with enhanced Th2 response

Axel P. Villani, Ana B. Pavel, Jianni Wu, Marie Fernandes, Catherine Maari, Etienne Saint-Cyr Proulx, Carolyn Jack, Jacob Glickman, Seulah Choi, Helen He, Benjamin Ungar, Yeriel Estrada, Naoya Kameyama, Ning Zhang, Juana Gonzales, Jean-Claude Tardif, James G. Krueger, Robert Bissonnette, Emma Guttman-Yassky

Summary: The study found significant correlations between vascular inflammation and Th2-related products in the skin and blood of AD patients, as well as atherosclerosis-related markers modulated by dupilumab. Circulating levels of endothelial microparticles were significantly higher in severe AD patients and tended to correlate with vascular inflammation.

ALLERGY (2021)

Article Dermatology

Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With Dupilumab

Daniela Mikhaylov, Ester Del Duca, Caroline Meyer Olesen, Helen He, Jianni Wu, Benjamin Ungar, Yeriel Estrada, Ning Zhang, Mashkura Chowdhury, Maja-Lisa Clausen, James G. Krueger, Ana B. Pavel, Tove Agner, Emma Guttman-Yassky

Summary: This study utilized tape-strips to obtain skin tissue from AD patients before and after dupilumab treatment for analysis of gene expression changes and therapeutic response biomarkers. Results showed significant modulation in key AD immune and barrier biomarkers with dupilumab treatment, which were correlated with clinical disease improvements.

DERMATITIS (2021)

Article Allergy

COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab

Benjamin Ungar, Jacob W. Glickman, Alexandra K. Golant, Celina Dubin, Olga Marushchak, Alyssa Gontzes, Daniela Mikhaylov, Giselle K. Singer, Danielle Baum, Nancy Wei, Antonio Sanin, Diana Gruenstein, Mark G. Lebwohl, Ana B. Pavel, Emma Guttman-Yassky

Summary: This study aimed to investigate the hypothesis that targeting Th2 with the IL4Ra-antagonist, dupilumab, could rebalance the Th1/Th2 axis in inflammatory disease patients, potentially leading to attenuated COVID-19 symptoms.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Editorial Material Biochemistry & Molecular Biology

Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery

Thomas U. Marron, Matthew D. Galsky, Bachir Taouli, Maria Isabel Fiel, Stephen Ward, Edward Kim, David Yankelevitz, Deborah Doroshow, Emma Guttman, Benjamin Ungar, Saurabh Mehandru, Benjamin J. Golas, Daniel Labow, John Sfakianos, Sujit S. Nair, Dimple Chakravarty, Michael Buckstein, Xiaoyu Song, Effi Kenigsberg, Sacha Gnjatic, Brian D. Brown, Joseph Sparano, Ashutosh Tewari, Myron Schwartz, Nina Bhardwaj, Miriam Merad

Summary: Window-of-opportunity trials offer a platform to understand the mechanisms of short-duration pre-surgical therapies, but there is a need for a paradigm shift in trial design, specimen collection, and analysis.

NATURE MEDICINE (2022)

Article Oncology

The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals

Jean-Eudes Fahrner, Imran Lahmar, Anne-Gaelle Goubet, Yacine Haddad, Agathe Carrier, Marine Mazzenga, Damien Drubay, Carolina Alves Costa Silva, Eric de Sousa, Cassandra Thelemaque, Clea Melenotte, Agathe Dubuisson, Arthur Geraud, Gladys Ferrere, Roxanne Birebent, Camille Bigenwald, Marion Picard, Luigi Cerbone, Joana R. Lerias, Ariane Laparra, Alice Bernard-Tessier, Benoit Kloeckner, Marianne Gazzano, Francois-Xavier Danlos, Safae Terrisse, Eugenie Pizzato, Caroline Flament, Pierre Ly, Eric Tartour, Nadine Benhamouda, Lydia Meziani, Abdelhakim Ahmed-Belkacem, Makoto Miyara, Guy Gorochov, Fabrice Barlesi, Alexandre Trubert, Benjamin Ungar, Yeriel Estrada, Caroline Pradon, Emmanuelle Gallois, Fanny Pommeret, Emeline Colomba, Pernelle Lavaud, Marc Deloger, Nathalie Droin, Eric Deutsch, Bertrand Gachot, Jean-Philippe Spano, Mansouria Merad, Florian Scotte, Aurelien Marabelle, Frank Griscelli, Jean-Yves Blay, Jean-Charles Soria, Miriam Merad, Fabrice Andre, Juliette Villemonteix, Mathieu F. Chevalier, Sophie Caillat-Zucman, Florence Fenollar, Emma Guttman-Yassky, Odile Launay, Guido Kroemer, Bernard La Scola, Markus Maeurer, Lisa Derosa, Laurence Zitvogel

Summary: This study investigates the polarity and specificity of memory T cells against SARS-CoV-2 viral lysates and peptides to determine factors associated with protection against COVID-19. The research reveals a potential imbalance in cytokine release and a specific T cell deficit that may contribute to susceptibility to COVID-19. Current vaccines show variable efficacy in triggering immune responses, suggesting the need for next-generation vaccines to address viral variants.

CANCER DISCOVERY (2022)

Review Pharmacology & Pharmacy

Current emerging and investigational drugs for the treatment of chronic hand eczema

Julia Cheng, Paola Facheris, Benjamin Ungar, Emma Guttman-Yassky

Summary: Chronic hand eczema (CHE) is a burdensome condition with limited treatment options. This review discusses the pathogenesis and currently available treatments for CHE, as well as emerging drugs being studied in clinical trials. Expert opinion suggests that immunomodulatory drugs such as JAK inhibitors and Th2-targeting antibodies hold promise for CHE treatment. Future management of CHE may involve more targeted therapies through clinical trials, moving away from broad immunosuppressants with more side effects.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)

Article Allergy

Dupilumab Improves Clinical Scores in Children and Adolescents With Moderate to Severe Atopic Dermatitis: A Real-World, Single-Center Study

Angel D. Pagan, Eden David, Benjamin Ungar, Sabrina Ghalili, Helen He, Emma Guttman-Yassky

Summary: This study reviewed the long-term treatment responses and adverse events of children and adolescents with atopic dermatitis (AD) treated with dupilumab. The results showed that dupilumab was effective and well-tolerated in treating pediatric and adolescent AD patients.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Article Allergy

Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseases

Ana B. Pavel, Ester Del Duca, Julia Cheng, Jianni Wu, Benjamin Ungar, Yeriel D. Estrada, Carolyn Jack, Catherine Maari, Etienne Saint-Cyr Proulx, Francisco Ramirez-Valle, James G. Krueger, Robert Bissonnette, Emma Guttman-Yassky

Summary: The treatment of inflammatory skin diseases needs experimental models of skin inflammation in humans to predict treatment effects. In this study, four common sensitizers were administered to healthy patients, and it was found that diphencyprone induced the strongest immune response and best modeled the barrier defects characteristic of atopic dermatitis and psoriasis.

ALLERGY (2023)

Letter Allergy

The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients

Benjamin Ungar, Susan Hartzell, Daniel Lozano-Ojalvo, Sabrina Ghalili, Swaroop Bose, Alexandra K. Golant, Kathryn Tan, Yeriel D. Estrada, Giselle K. Singer, Ana B. Pavel, Paolo Cravedi, Emma Guttman-Yassky

ALLERGY (2023)

Letter Dermatology

Use of dynamic optical coherence tomography in a corticosteroid vasoconstrictor assay: a pilot study

Shayan Owji, Helen He, Joseph Han, Peter Baek, Daniel Yassky, Nicholas Gulati, Benjamin Ungar, Jonathan Ungar

INTERNATIONAL JOURNAL OF DERMATOLOGY (2023)

Review Allergy

Management of Atopic Dermatitis: Clinical Utility of Ruxolitinib

Shayan Owji, Stella A. Caldas, Benjamin Ungar

Summary: The ruxolitinib cream showed high efficacy and favorable safety profile in treating atopic dermatitis patients.

JOURNAL OF ASTHMA AND ALLERGY (2022)

Letter Dermatology

Alopecia areata is associated with increased genetic risk of myocardial infarction: A Mendelian randomization study

Ross O'Hagan, Stella A. Caldas, Joel Correa M. da Rosa, Emma Guttman-Yassky, Benjamin Ungar

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Letter Allergy

The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis

Benjamin Ungar, Leore Lavin, Alexandra K. Golant, Alyssa Gontzes, Eden David, Yeriel D. Estrada, Giselle K. Singer, Ana B. Pavel, Emma Guttman-Yassky

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2022)

暂无数据